19F and 1H MRI detection of amyloid β plaques in vivo

Nature Neuroscience

Volumn 8, Issue 4, 2005, Pages 527-533

  Higuchi, Makoto ^a   Iwata, Nobuhisa ^a   Matsuba, Yukio ^a   Sato, Kumi ^b   Sasamoto, Kazumi ^b   Saido, Takaomi C ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b Dojin Laboratories   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 2,5 BIS(3 HYDROXYCARBONYL 4 HYDROXY)STYRYLBENZENE; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; FLUORESCENT DYE; UNCLASSIFIED DRUG; 1 AMINO 3 FLUOROMETHYL 5 METHYLADAMANTANE; 1-AMINO-3-FLUOROMETHYL-5-METHYLADAMANTANE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; ENOLASE; MEMANTINE; TRITIUM;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EARLY DIAGNOSIS; NEUROIMAGING; NEUROPATHOLOGY; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENILE PLAQUE; TRANSGENIC MOUSE; AGE; ANIMAL; BRAIN; BRAIN LEVEL; CELL COUNT; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MOUSE; PATHOLOGY; PHYSIOLOGY; SCINTISCANNING; STAINING; THREE DIMENSIONAL IMAGING; TIME;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMALS; BRAIN; BRAIN CHEMISTRY; CELL COUNT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT DYES; HUMANS; IMAGING, THREE-DIMENSIONAL; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MEMANTINE; MICE; MICE, TRANSGENIC; PHOSPHOPYRUVATE HYDRATASE; SENILE PLAQUES; STAINING AND LABELING; TIME FACTORS; TRITIUM;

EID: 20044392910     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1422     Document Type: Article

References (29)

1. Selkoe, D.J. Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53, 438-447 (1994).
2. Goedert, M., Trojanowski, J.Q. & Lee, V.M.-Y. The Molecular and Genetic Basis of Neurological Diseases 2nd edn. (Butterworth, Boston, 1997).
3. Hardy, J. & Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
4. Gomez-Isla, T. et al. Profound loss of layer II entorhinal cortex neurons occur in very mild Alzheimer's disease. J. Neurosci. 16, 4491-4500 (1996).
5. Mathis, C.A. et al. A lipophilic thioflavin-T derivatives for position emission tomography (PET) imaging of amyloid in brain. Bioorg. Med. Chem. 12, 295-298 (2002).
6. Kung, M-P. et al. IMPY: an improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques. Brain Res. 956, 202-210 (2002).
7. Klunk, W.E. et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann. Neurol. 55, 306-319 (2004).
8. Okamura, N. et al. Styrylbenzoxazol derivatives for in vivo imaging of amyloid plaques in the brain. J. Neurosci. 24, 2535-2541 (2004).
9. Shoghi-Jadid, K. et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am. J. Geriatr. Psychiatry 10, 24-35 (2002).
10. Sair, H.I., Doraiswamy, P.M. & Petrella, J.R. In vivo amyloid imaging in Alzheimer's disease. Neuroradiology 46, 93-104 (2004).
11. Skovronsky, D.M. et al. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 97, 7609-7614 (2000).
12. Nordberg, A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol. 3, 519-527 (2004).
13. Bacskai, B.J. et al. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic mice. Proc. Natl. Acad. Sci. USA 100, 12462-12467 (2003).
14. Bacskai, B.J. et al. Imaging of amyloid β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat. Med. 7. 369-372 (2001).
15. Benveniste, H., Einstein, G., Kim, K.R., Hulette, C. & Johnson, G.A. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc. Natl. Acad. Sci. USA 96, 14079-14084 (1999).
16. Poduslo, J.F. et al. Molecular targeting of Alzheimer's disease amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol. Aging 11, 315-329 (2002).
17. Wadghiri, Y.Z. et al. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magnet. Reson. Med. 50, 293-302 (2003).
18. Zhang, J. et al. Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging. Magnet. Reson. Med. 51, 452-457 (2004).
19. Helpern, J.A. et al. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magnet. Reson. Med. 51, 794-798 (2004).
20. Lee, S.P. et al. Visualization of β-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Magnet. Reson. In Med. 52, 538-544 (2004).
21. Jack, C.R. Jr. et al. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magnet. Reson. In Med. 52, 1263-1271 (2004).
22. 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques. Eur. J. Med. Chem. 39, 573-578 (2004).
23. Hsiao, K. et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
24. Zhuang, Z-P. et al. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J. Med. Chem. 44, 1905-1914 (2001).
25. Lorenzo, A. & Yankner, B.A. β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo Red. Proc. Natl. Acad. Sci. USA 91, 12243-12247 (1994).
26. Saido, T.C. Aβ Metabolism and Alzheimer's Disesse (Landes Bioscience. Georgetown. Texas, USA, 2003).
27. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the NIA Working Group. Consensus report of the Working Group on: 'Molecular and Biochemical Markers of Alzheimer's Disease. Neurobiol. Aging 19, 109-116 (1998)
28. N3(pE), in senile plaques. Neuron 14, 457-466 (1995).
29. Hennig, J., Nauerth, A. & Friedburg, H. RARE imaging: a fast imaging method for clinical MR. Magn. Reson. Med. 3, 823-833 (1986).